Telemedicine Improves Pain-related Disabilities in Following up Cancer Pain Outpatient

Not Applicable

Recruiting

• Conditions: Cancer Pain; Pain, Chronic
• Interventions: Other: Telemedicine; Other: In-person

• Registration Number: NCT05628246
• Lead Sponsor: Mahidol University

Brief Summary

Cancer is the second leading cause of death worldwide, with approximately 18.1 million new cases and 9.6 million deaths reported in 2018. Cancer-related pain is experienced by 50-70% of patients, with a higher prevalence at advanced disease stages (66.4%). Since the development of WHO's cancer pain guidelines, several studies have reported good relief of symptoms and suffering for a majority of patients. Recent reports suggest that up to 50% of patients still report insufficient pain control. Patients with cancer often present with multiple symptoms and functional decline. Evidence supports multidisciplinary approaches to address symptoms and suffering, including early palliative care referral

From review literatures we found that the telemedicine group had significantly higher quality of life than the usual care group. In addition, the telemedicine group had lower anxiety and depression scores than the usual care group.

Therefore, we will conduct the non-randomized controlled study of using telemedicine comparing to conventional in-person at OPD in hospitalized cancer pain patients.

The purpose of this study is to assess the pain interference by using the Brief Pain Inventory (BPI) and to compare between the in-person group and the telemedicine group. To assess the cost-effectiveness of telemedicine for reducing symptoms associated with cancer and its treatment.

Detailed Description

The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group at 1 month.

Study Timeline

• Study First Submitted: 2022-11-15
• Study First Submitted QC: 2022-11-24
• Study First Posted: 2022-11-28
• Status Verified: 2023-01
• Study Start: 2023-01-19
• Last Update Submitted: 2023-01-26
• Last Update Posted: 2023-01-27
• Primary Completion: 2025-07-17
• Study Completion: 2025-07-17

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 206

Inclusion Criteria

• Age older than 18 years old
• Cancer patients who new visit as out patient at pain clinic, Siriraj hospital

Exclusion Criteria

• Cannot read and write
• Confusion
• Unable to use the 0-10 Numerical Rating Scale (NRS) to rate pain intensity.
• Unstable clinical presentation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Telemedicine	Telemedicine	Telemedicine
In-person	In-person	Face to face at OPD

Primary Outcome Measures

Name	Time	Method
Pain interference	at 1 month	The pain interference will be assessed and compared using Brief Pain Inventory from 0-70 between In-person group and telemedicine group.

Secondary Outcome Measures

Name	Time	Method
Pain intensity	at 1 month, 2 months and 3 months	The pain reduction will be assessed and compared using numerical rating (NRS) from 0-10; 0 designating "no pain" and 10 designating " worst possible pain" scale between In-person group and telemedicine group.
Quality of life (QoL)	at 1 month	The quality of life will be assessed and compared using EuroQoL 5D5L between In-person group and telemedicine group.

Trial Locations

Locations (1)

Faculty of medicine Siriraj Hospital Mahidol University; 🇹🇭 Bangkoknoi, Bangkok, Thailand